Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review

Surekha Tayade; Sangeeta Rai; Hrishikesh Pai; Madhuri Patel; Nidhi Makhija

doi:10.7759/cureus.36729

journal article Mar 27, 2023

Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review

Surekha Tayade

Sangeeta Rai Hrishikesh Pai Madhuri Patel Nidhi Makhija

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.36729

Topics

No keywords indexed for this article. Browse by subject →

References

21

[1]

Sachedina A, Todd N. Dysmenorrhea, endometriosis and chronic pelvic pain in adolescents. J Clin Res Pediatr Endocrinol. 2020, 12:7-17. 10.4274/jcrpe.galenos.2019.2019.S0217 10.4274/jcrpe.galenos.2019.2019.s0217

[2]

Pirtea P, de Ziegler D, Ayoubi JM. Diagnosing endometriosis in adolescents: ultrasound is a game changer. Fertil Steril. 2020, 114:967-8. 10.1016/j.fertnstert.2020.07.039 10.1016/j.fertnstert.2020.07.039

[3]

Dun EC, Kho KA, Morozov VV, Kearney S, Zurawin JL, Nezhat CH. Endometriosis in adolescents. JSLS. 2015, 19:e2015.00019. 10.4293/JSLS.2015.00019 10.4293/jsls.2015.00019

[4]

Murji A, Biberoğlu K, Leng J, Mueller MD, Römer T, Vignali M, Yarmolinskaya M. Use of dienogest in endometriosis: a narrative literature review and expert commentary. Curr Med Res Opin. 2020, 36:895-907. 10.1080/03007995.2020.1744120 10.1080/03007995.2020.1744120

[5]

Seo YS, Yuk JS, Cho YK, Shin JY. Dienogest and the risk of reoperation in endometriosis. J Pers Med. 2021, 11:924. 10.3390/jpm11090924 10.3390/jpm11090924

[6]

Ebert AD, Dong L, Merz M, et al.. Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents. J Pediatr Adolesc Gynecol. 2017, 30:560-7. 10.1016/j.jpag.2017.01.014 10.1016/j.jpag.2017.01.014

[7]

Yu Q, Zhang S, Li H, et al.. Dienogest for treatment of endometriosis in women: a 28-week, open-label, extension study. J Womens Health (Larchmt). 2019, 28:170-7. 10.1089/jwh.2018.7084 10.1089/jwh.2018.7084

[8]

Ota I, Ota Y, Taniguchi F. Impact of 1.0 mg/day dienogest treatment on bone metabolism markers in young women with dysmenorrhea. Endocrines. 2021, 2:293-300. 10.3390/endocrines2030027 10.3390/endocrines2030027

[9]

Malik R, Mann MK. Role of dienogest in endometriosis in young women. J Obstet Gynaecol India. 2021, 71:522-9. 10.1007/s13224-021-01483-0 10.1007/s13224-021-01483-0

[10]

Luisi S, Parazzini F, Angioni S, et al.. Dienogest treatment improves quality of life in women with endometriosis. J Endometr Pelvic Pain Disord. 2015, 7:124-8. 10.5301/je.5000232 10.5301/je.5000232

[11]

Uludag SZ, Demirtas E, Sahin Y, Aygen EM. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. J Obstet Gynaecol. 2021, 41:1246-51. 10.1080/01443615.2020.1867962 10.1080/01443615.2020.1867962

[12]

Miao J, Lu J, Tang J, Lu P. Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice. Gynecol Endocrinol. 2022, 38:656-60. 10.1080/09513590.2022.2098948 10.1080/09513590.2022.2098948

[13]

Gordts S, Koninckx P, Brosens I. Pathogenesis of deep endometriosis. Fertil Steril. 2017, 108:872-885.e1. 10.1016/j.fertnstert.2017.08.036 10.1016/j.fertnstert.2017.08.036

[14]

Ferrero S, Remorgida V, Venturini PL, Bizzarri N. Endometriosis: the effects of dienogest. BMJ Clin Evid. 2015, 2015:0802.

[15]

Techatraisak K, Hestiantoro A, Soon R, et al.. Impact of long-term dienogest therapy on quality of life in Asian women with endometriosis: the prospective non-interventional study ENVISIOeN. Reprod Sci. 2022, 29:1157-69. 10.1007/s43032-021-00787-w 10.1007/s43032-021-00787-w

[16]

Vignali M, Belloni GM, Pietropaolo G, Barbasetti Di Prun A, Barbera V, Angioni S, Pino I. Effect of dienogest therapy on the size of the endometrioma. Gynecol Endocrinol. 2020, 36:723-7. 10.1080/09513590.2020.1725965 10.1080/09513590.2020.1725965

[17]

Kizilkaya Y, Ibanoglu MC, Kıykac Altinbas S, Engin-Ustun Y. A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecol Endocrinol. 2022, 38:403-6. 10.1080/09513590.2022.2053956 10.1080/09513590.2022.2053956

[18]

Ji M, Yuan M, Jiao X, Li Q, Huang Y, Li J, Wang G. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea. Gynecol Endocrinol. 2022, 38:164-9. 10.1080/09513590.2021.2000961 10.1080/09513590.2021.2000961

[19]

Angioni S, Pontis A, Malune ME, et al.. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020, 36:84-6. 10.1080/09513590.2019.1640674 10.1080/09513590.2019.1640674

[20]

Muzii L, Galati G, Di Tucci C, et al.. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020, 36:81-3. 10.1080/09513590.2019.1640199 10.1080/09513590.2019.1640199

[21]

Angioni S, Nappi L, Pontis A, Sedda F, Luisi S, Mais V, Melis GB. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study. Gynecol Endocrinol. 2015, 31:406-8. 10.3109/09513590.2015.1006617 10.3109/09513590.2015.1006617

Metrics

0

Citations

21

References

Details

Published: Mar 27, 2023

Authors

Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India

M

Madhuri Patel

Nowrosjee Wadia Maternity Hospital, Mumbai, Maharashtra, India

N

Nidhi Makhija

Cite This Article

Surekha Tayade, Sangeeta Rai, Hrishikesh Pai, et al. (2023). Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.36729

Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review

You May Also Like